Style | Citing Format |
---|---|
MLA | Emami J, et al.. "Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer." Pharmaceutical Development and Technology, vol. 25, no. 4, 2020, pp. 492-509. |
APA | Emami J, Kazemi M, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A (2020). Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer. Pharmaceutical Development and Technology, 25(4), 492-509. |
Chicago | Emami J, Kazemi M, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A. "Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer." Pharmaceutical Development and Technology 25, no. 4 (2020): 492-509. |
Harvard | Emami J et al. (2020) 'Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer', Pharmaceutical Development and Technology, 25(4), pp. 492-509. |
Vancouver | Emami J, Kazemi M, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A. Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer. Pharmaceutical Development and Technology. 2020;25(4):492-509. |
BibTex | @article{ author = {Emami J and Kazemi M and Hasanzadeh F and Minaiyan M and Mirian M and Lavasanifar A}, title = {Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer}, journal = {Pharmaceutical Development and Technology}, volume = {25}, number = {4}, pages = {492-509}, year = {2020} } |
RIS | TY - JOUR AU - Emami J AU - Kazemi M AU - Hasanzadeh F AU - Minaiyan M AU - Mirian M AU - Lavasanifar A TI - Novel Ph-Triggered Biocompatible Polymeric Micelles Based on Heparin–Α-Tocopherol Conjugate for Intracellular Delivery of Docetaxel in Breast Cancer JO - Pharmaceutical Development and Technology VL - 25 IS - 4 SP - 492 EP - 509 PY - 2020 ER - |